Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Is It Too Late to Buy Eli Lilly? Billionaire Ken Griffin Doesn't Think So. He Nearly Quadrupled His Stake in the Pharma Stock in Q2.

Key PointsObesity drugs like Mounjaro and Zepbound could help the drugmaker power ahead for years.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Wednesday 26 August →